Blog

To view blog posts prior to July 2010, click here.

The Memphis Business Group on Health (MBGH) is pleased to make this forum, including all web pages and web sites accessed from this page, available to Web Site users and others. However, the MBGH does not render legal or consultation services, and legal counsel must be consulted to determine any material’s applicability to any specific situation. MBGH cannot warrant or control the quality, accuracy, or validity of the information posted here. Comments posted on this blog are the sole responsibility of their writers. Use of such information is at the risk of the accessing user and the accessing user assumes all liabilities that may result from such use.


New York Times Editorial Calls for Reduced Cost of Hep C Drugs

This New York Times (NYT) editorial lays out the tension in the current debate over the very expensive (@$84,000/treatment un-discounted) Hepatitis C drugs: broad coverage that will significantly increase health plan costs or restricted coverage to keep costs under control but that will not benefit as many patients.

In the end, the NYT points out that manufacturers generally pay what the market will bear so calls for public and private insurers to push for lower pricing, which can support providing these drugs to more people.

MBGH is kicking off a specialty pharmacy management initiative for members which addresses this very issue. The initiative provides hands-on training, data analysis and, most importantly, technical assistance and consulting, that employers need to actually achieve cost savings in specialty spend while still making these drugs accessible to their employees and families. Contact Cristie Travis at ctravis@memphisbusinessgroup.org for more information.

Read the editorial

Posted by Cristie Travis at 8:19 AM

Comments

No Comments yet!

Leave A Comment

Please answer the simple math question below to submit the form.
1 + 2 =

From Our Blog

Say Hello

Please feel free to drop us a line via the button below. We try to respond to every email we receive.

Stay Connected

Join the MBGH community and keep up to date with issues concerning Memphis healthcare.

Facebook Twitter LinkedIn Feed